Influenza Trials in Huntsville, United States
Conditions / Influenza / Huntsville, United States
Research into Influenza spans multiple therapeutic approaches and trial phases.
17 total trials for this combination
Showing top 10 of 17 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00753272 | Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older | COMPLETED | PHASE3 |
| NCT01992107 | Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old | COMPLETED | PHASE3 |
| NCT00772109 | Study of Fluzone Vaccine Administered by Intradermal Route in Comparison With Standard Fluzone® in Adults | COMPLETED | PHASE3 |
| NCT01011049 | Study of Influenza Vaccine Revaccination in Healthy Adults Previously Vaccinated With Fluzone ID or Fluzone IM | COMPLETED | PHASE2 |
| NCT01712984 | Study of Intradermal Quadrivalent Influenza Vaccine in Adults Aged 18 Through 64 Years | COMPLETED | PHASE3 |
| NCT01992094 | Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older | COMPLETED | PHASE3 |
| NCT02989194 | Study of an Investigational Monoclonal Antibody, VIS410, in Subjects With Uncomplicated Influenza A | COMPLETED | PHASE2 |
| NCT01068912 | Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza | COMPLETED | PHASE2 |
| NCT00616928 | Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years | COMPLETED | PHASE3 |
| NCT02008344 | Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults | COMPLETED | PHASE3 |